MarketPulse

vaccine development

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

ELISpot & FluoroSpot Market Set for 7.1% Growth Through 2031

Global ELISpot & FluoroSpot assay market to grow at 7.1% CAGR through 2031, driven by immunology research and personalized therapies.
MRKTMOBDXBIOBIO.B+1automationpersonalized medicine
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Evaxion Schedules 2026 AGM as AI-Powered Vaccine Pipeline Advances

Danish biotech $EVAX announces April 2026 Annual General Meeting in Copenhagen while advancing AI-driven cancer and infectious disease vaccines.
EVAXAnnual General Meetingclinical pipeline
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Evaxion to Report 2025 Results, Showcase AI-Immunology Platform Progress

Danish biotech $EVAX will announce full-year 2025 financial results and business update March 5, detailing AI-Immunology platform development across oncology, infectious disease, and autoimmune applications.
EVAXfinancial resultsclinical-stage